Several European biotechs, including Cellbox Labs, Evotec SE, Nanolive SA, and Salipro Biotech AB, have developed innovative ...

A retrospective analysis of anti–B-cell maturation antigen (BCMA) chimeric antigen receptor T-cell (CAR T) therapy outcomes ...

A U-shaped relationship between BMI and CAR T-cell therapy outcomes was observed, with overweight patients showing poorer PFS ...

Dr Katherine Ruzhansky reviews therapeutic advances that emphasize careful patient selection and individualized combination ...

Indaptus Therapeutics, Inc. (Nasdaq: INDP) (“Indaptus” or the “Company”), a clinical stage biotechnology company dedicated to pioneering innovative cancer and viral infection treatments, today ...

Five-year follow-up data from the global, phase 2 JULIET (NCT02445248)trial, which evaluated the chimeric antigen receptor (CAR)T-cell therapy tisagenlecleucel (tisa-cel; Kymriah) in patients with ...

DKMS study data presented at the DGHO Annual Meeting 2025 in Cologne indicate the biological age of donors has a greater influence on transplant success than previously assumed [1]. “Our results show ...

Cell has revised the schedule for CAP Round-4 admissions for BAMS, BHMS, and BUMS courses for 2025-26 academic year after ...

This article examines some of the cell-based approaches that researchers are using to study acquired drug resistance and the ...

Sjögren's disease, a heterogeneous autoimmune disorder characterized by exocrine glandular dysfunction, has a wide spectrum of manifestations. Clinical symptoms can be difficult to characterize, and ...

This will be the first time that an additional CAP round will be held for AYUSH courses, which are placed under group B in ...

At the Institute for Value-Based Medicine ® event in New Orleans, Louisiana, on November 4, Clark Alsfeld, MD, a hematology ...